These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22869181)

  • 1. TRP-ing up brain tumors.
    Schonberg DL; Bao S; Rich JN
    Nat Med; 2012 Aug; 18(8):1175-6. PubMed ID: 22869181
    [No Abstract]   [Full Text] [Related]  

  • 2. Capsaicin-induced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation.
    Amantini C; Mosca M; Nabissi M; Lucciarini R; Caprodossi S; Arcella A; Giangaspero F; Santoni G
    J Neurochem; 2007 Aug; 102(3):977-90. PubMed ID: 17442041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations.
    De Lago E; Gustafsson SB; Fernández-Ruiz J; Nilsson J; Jacobsson SO; Fowler CJ
    J Neurochem; 2006 Oct; 99(2):677-88. PubMed ID: 16899063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transcriptional regulation of 5'-untranslated regions of human Transient Receptor Potential Vanilloid type-1 (TRPV-1) channels: role in the survival of glioma patients.
    Nabissi M; Morelli MB; Arcella A; Cardinali C; Santoni M; Bernardini G; Santoni A; Santoni G; Amantini C
    Oncotarget; 2016 Dec; 7(49):81541-81554. PubMed ID: 27829230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and glioma therapy.
    Woolf EC; Scheck AC
    CNS Oncol; 2012 Sep; 1(1):7-10. PubMed ID: 25054292
    [No Abstract]   [Full Text] [Related]  

  • 6. Uptake of tritiated methotrexate by mouse brain tumors after intravenous or intrathecal administration.
    Ushio Y; Hayakawa T; Mogami H
    J Neurosurg; 1974 Jun; 40(6):706-16. PubMed ID: 4406460
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of chemotherapy on glioma metabolism.
    Maker HS
    Arch Neurol; 1991 Jun; 48(6):569-70. PubMed ID: 2039374
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glioma and free radical].
    Yoshii Y
    No Shinkei Geka; 1998 Jul; 26(7):571-81. PubMed ID: 9666490
    [No Abstract]   [Full Text] [Related]  

  • 9. Human glioma lines as experimental model for biological and chemosensitivity studies.
    Leonetti C; D'Agnano I; Del Bufalo D; Carapella CM; Zupi G
    J Neurosurg Sci; 1989; 33(1):39-42. PubMed ID: 2674355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Animal models of human glioma: the progress of application and investigation].
    Zhu HF; Zhang YX; Zhao XD
    Dongwuxue Yanjiu; 2012 Jun; 33(3):337-42. PubMed ID: 22653863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioma progression through synaptic activity.
    Lim-Fat MJ; Wen PY
    Nat Rev Neurol; 2020 Jan; 16(1):6-7. PubMed ID: 31745299
    [No Abstract]   [Full Text] [Related]  

  • 12. The uptake, distribution, and antitumor activity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the murine glioma.
    Levin VA; Shapiro WR; Clancy TP; Oliverio VT
    Cancer Res; 1970 Oct; 30(10):2451-5. PubMed ID: 5474173
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential biochemical therapy of glioma cancer.
    Yin LT; Fu YJ; Xu QL; Yang J; Liu ZL; Liang AH; Fan XJ; Xu CG
    Biochem Biophys Res Commun; 2007 Oct; 362(2):225-9. PubMed ID: 17707767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Problems of chemotherapy for glioma].
    Hirose Y
    Gan To Kagaku Ryoho; 2011 Jun; 38(6):923-6. PubMed ID: 21751527
    [No Abstract]   [Full Text] [Related]  

  • 15. Silibinin: a thorny therapeutic for EGF-R expressing tumors?
    Hannay JA; Yu D
    Cancer Biol Ther; 2003; 2(5):532-3. PubMed ID: 14614321
    [No Abstract]   [Full Text] [Related]  

  • 16. Finding drugs against CD133+ glioma subpopulations.
    Nakano I; Chiocca EA
    J Neurosurg; 2011 Mar; 114(3):648; discussion 648-50. PubMed ID: 21054138
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug Repurposing of Metabolic Agents in Malignant Glioma.
    Seliger C; Hau P
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics in intra-arterial ACNU therapy in malignant brain tumors].
    Okumura T; Yamashita J; Tokuriki Y; Handa H; Iwakawa S; Tsukamoto T; Okumura K; Hori R
    Neurol Med Chir (Tokyo); 1987 Jun; 27(6):491-7. PubMed ID: 2448667
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-angiogenesis treatment for brain tumors: present and future].
    Takano S; Matsumura A
    No Shinkei Geka; 2006 Jul; 34(7):657-78. PubMed ID: 16841703
    [No Abstract]   [Full Text] [Related]  

  • 20. Paving new pathways.
    Rothstein JD
    Nat Med; 2002 Sep; 8(9):938-40. PubMed ID: 12205454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.